|
1) Kobayashi M, Yamamoto M. Molecular mecha-nisms activating the Nrf2-Keap1 pathway of anti-oxidant gene regulation. Antioxid Redox Signal. 2005; 7: 385-94
|
|
|
|
2) Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004; 10: 549-57
|
|
|
|
|
|
3) Itoh K, Wakabayashi N, Katoh Y, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999; 13: 76-86
|
|
|
|
|
|
4) Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, et al. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci U S A. 2004; 101: 2040-5
|
|
|
|
|
|
5) Zhang DD, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol. 2003; 23: 8137-51
|
|
|
|
|
|
6) Kobayashi A, Kang MI, Okawa H, et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol. 2004; 24: 7130-9
|
|
|
|
|
|
7) Cullinan SB, Gordan JD, Jin J, et al. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol. 2004; 24: 8477-86
|
|
|
|
|
|
8) Zhang DD, Lo SC, Cross JV, et al. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol. 2004; 24: 10941-53
|
|
|
|
|
|
9) Furukawa M, Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol. 2005; 25: 162-71
|
|
|
|
|
|
10) McMahon M, Itoh K, Yamamoto M, et al. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem. 2003; 278: 21592-600
|
|
|
|
|
|
11) Stewart D, Killeen E, Naquin R, et al. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J Biol Chem. 2003; 278: 2396-402
|
|
|
|
|
|
12) Kobayashi A, Kang MI, Watai Y, et al. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol. 2006; 26: 221-9
|
|
|
|
|
|
13) Chow CW, Abreu MTH, Suzuki T, et al. Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol. 2003; 29: 427-31
|
|
|
|
|
|
14) Cho HY, Jedlicka AE, Reddy SP, et al. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol. 2002; 26: 175-82
|
|
|
|
|
|
15) Chan K, Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci U S A. 1999; 96: 12731-6
|
|
|
|
|
|
16) Mochizuki M, Ishii Y, Itoh K, et al. Role of 15-deoxyΔ12, 14 prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. Am J Respir Crit Care Med. 2005; 171: 1260-6
|
|
|
|
|
|
17) Cho HY, Jedlicka AE, Reddy SP, et al. Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene. Am J Respir Cell Mol Biol. 2002; 26: 42-51
|
|
|
|
|
|
18) Marzec JM, Christie JD, Reddy SP, et al. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J. 2007; 21: 2237-46
|
|
|
|
|
|
19) 2006 Global Initiative for Chronic Obstructive Lung Disease. National Institute of Health. 2006
|
|
|
|
|
|
20) Rangasamy T, Cho CY, Thimmulappa RK, et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest. 2004; 114: 1248-59
|
|
|
|
|
|
21) Iizuka T, Ishii Y, Itoh K, et al. Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells. 2005; 10: 1113-25
|
|
|
|
|
|
22) Ishii Y, Itoh K, Morishima Y, et al. Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol. 2005; 175: 6968-75
|
|
|
|
|
|
23) Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med. 2001; 345: 517-25
|
|
|
|
|
|
24) Cho HY, Reddy SP, Yamamoto M, et al. The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J. 2004; 18: 1258-60
|
|
|
|
|
|
25) Rangasamy T, Guo J, Mitzner WA, et al. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med. 2005; 202: 47-59
|
|
|
|
|
|
26) King MR, Ismail AS, Davis LS, et al. Oxidative stress promotes polarization of human T cell differentiation toward a T helper 2 phenotype. J Immunol. 2006; 176: 2765-72
|
|
|
|
|
|
27) Thimmulappa RK, Lee H, Rangasamy T, et al. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest. 2006; 116: 984-95
|
|
|
|
|
|
28) Lee JS, Surh YJ. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 2005; 224: 171-84
|
|
|
|
|
|
29) Singh A, Misra V, Thimmulappa RK, et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 2006; 3: 1865-76
|
|
|
|
|
|
30) Padmanabhan B, Tong KI, Ohta T, et al. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol Cell. 2006; 21: 689-700
|
|
|
|
|